HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jack A. Roth Harvey I. Pass Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pogrebniak, H. W. Articles by Pass, H. I. Search for Related Content PubMed PubMed Citation Articles by Pogrebniak, H. W. Articles by Pass, H. I.

Ann Thorac Surg 1988;46:20-23
© 1988 The Society of Thoracic Surgeons

---

Articles

Resection of Pulmonary Metastases from Malignant Melanoma: Results of a 16-Year Experience

Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

^* Address reprint requests to Dr. Pass, Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bldg 10, Room 2B07, Bethesda, MD 20892

Between 1970 and 1986, 49 patients had resection of presumed pulmonary metastases from malignant melanoma. Sixteen patients were found to have benign disease only despite the appearance of a new nodule in 13. Patients with benign disease had a significantly longer mean survival (169 months) compared with the group with malignant disease (22 months). Median survival for all patients with malignant disease was 13 months. Survival after resection did not correlate with the Clark level of the original lesion, lymph node status, disease-free interval, or number of nodules on preoperative tomograms. Two of 10 patients with 1 nodule resected are long-term survivors (88 and 120 months). Exploration in patients with presumed pulmonary metastases from melanoma is justified to rule out benign disease even if a new solitary nodule is detected. There are no prognostic indicators predicting survival after resection of melanoma metastases, and a significant number of patients will have benign disease.

This article has been cited by other articles:

				J. H. Robert, V. Ambrogi, B. Mermillod, D. Dahabreh, and P. Goldstraw Factors Influencing Long-Term Survival After Lung Metastasectomy Ann. Thorac. Surg., March 1, 1997; 63(3): 777 - 784. [Abstract] [Full Text]

				L. A. Gorenstein, J. B. Putnam, G. Natarajan, C. A. Balch, and J. A. Roth Improved survival after resection of pulmonary metastases from malignant melanoma Ann. Thorac. Surg., August 1, 1991; 52(2): 204 - 210. [Abstract] [PDF]